Serveur d'exploration SRAS - Analysis (2020)

Index « Titre (en) » - entrée « chinese »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
china < chinese < chloroquine  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000029 (2020) Yu-Shi Zhang [République populaire de Chine] ; Wei-Hong Cong [République populaire de Chine] ; Jing-Jing Zhang [République populaire de Chine] ; Fei-Fei Guo [République populaire de Chine] ; Hong-Mei Li [République populaire de Chine][Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
000032 (2020) Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine][Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
000100 (2020) Chang-Quan LingTraditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)
000101 (2020) Yang Yang ; Md Sahidul Islam ; Jin Wang ; Yuan Li ; Xin ChenTraditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
000114 (2020) Yu Han [République populaire de Chine] ; Hailan Yang [République populaire de Chine]The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective.
000279 (2020) Jie Wang ; Haiting Feng [République populaire de Chine] ; Sheng Zhang [République populaire de Chine] ; Zuowei Ni [République populaire de Chine] ; Lingmei Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Lixin Zhuo ; Zifeng Zhong [République populaire de Chine] ; Tingting Qu [République populaire de Chine]SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital.
000354 (2020) Pengcheng Zhou [République populaire de Chine] ; Zebing Huang [République populaire de Chine] ; Yinzong Xiao [République populaire de Chine] ; Xun Huang [République populaire de Chine] ; Xue-Gong Fan [République populaire de Chine]Protecting Chinese Healthcare Workers While Combating the 2019 Novel Coronavirus.
000458 (2020) Shengwei Yu [République populaire de Chine] ; Junwu Wang [République populaire de Chine] ; Haitao Shen [République populaire de Chine]Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19.
000499 (2020) Fujun Peng [République populaire de Chine] ; Lei Tu [République populaire de Chine] ; Yongshi Yang [République populaire de Chine] ; Peng Hu [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Qinyong Hu [République populaire de Chine] ; Feng Cao [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Christopher Chang [États-Unis]Management and Treatment of COVID-19: The Chinese Experience
000883 (2020) Hui Luo [République populaire de Chine] ; Qiao-Ling Tang [République populaire de Chine] ; Ya-Xi Shang [République populaire de Chine] ; Shi-Bing Liang [République populaire de Chine] ; Ming Yang [République populaire de Chine] ; Nicola Robinson [République populaire de Chine] ; Jian-Ping Liu [République populaire de Chine]Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs
000902 (2020) Kam Wa Chan [Hong Kong] ; Vivian Taam Wong [Hong Kong] ; Sydney Chi Wai Tang [Hong Kong]COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease.
000A40 (2020) A-Yong Yu ; Ruixue Tu ; Xu Shao ; Anpeng Pan ; Kaijing Zhou ; Jinhai HuangA comprehensive Chinese experience against SARS-CoV-2 in ophthalmology
000A57 (2020) T M Wassenaar [Allemagne] ; Y. Zou [République populaire de Chine]2019_nCoV/SARS-CoV-2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses.
000A88 (2007) Ronald Keith [Australie] ; Zhiqiu Lin [Canada]SARS in Chinese Politics and Law
000A96 (2005) Zu Shuxian [République populaire de Chine] ; Peter J. Li [États-Unis] ; Pei-Feng SuAnimal Welfare Consciousness of Chinese College Students

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "chinese" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "chinese" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    chinese
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021